,file,ref_number,ref_text,doi,doi_url
0,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_9,[1],"Glynne-Jones R, Wyrwicz L, Tiret E, et al. 2017. Ann Oncol. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.",10.1093/annonc/mdx224,https://doi.org/10.1093/annonc/mdx224
1,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_9,[2],"Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. 2006. J Clin Oncol. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.",10.1002/bjs.5506,https://doi.org/10.1002/bjs.5506
2,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_9,[3],"Gerard JP, Conroy T, Bonnetain F, et al. 2006. J Clin Oncol. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.",10.1200/jco.2006.06.7629,https://doi.org/10.1200/jco.2006.06.7629
3,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_9,[4],"Sauer R, Becker H, Hohenberger W, et al. 2004. N Engl J Med. Preoperative versus postoperative chemoradiotherapy for rectal cancer.",10.1056/nejmoa040694,https://doi.org/10.1056/nejmoa040694
4,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_9,[5],"Heald RJ, Ryall RD. 1986. Lancet. Recurrence and survival after total mesorectal excision for rectal cancer.",10.1016/s0140-6736(86)91510-2,https://doi.org/10.1016/s0140-6736(86)91510-2
5,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_9,[6],"Andr√© T, Boni C, Navarro M, et al. 2009. J Clin Oncol. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.",10.1200/jco.2008.20.6771,https://doi.org/10.1200/jco.2008.20.6771
